Fibrosarcoma
MONDO:0005164A malignant mesenchymal fibroblastic neoplasm affecting the soft tissue and bone.
Also known as: fibrocytic tumor, fibrocytic tumour, fibrosarcoma, fibrosarcoma (disease), fibrosarcoma (excluding infantile fibrosarcoma), fibrosarcoma - not infantile, fibrosarcoma, malignant, malignant fibromatous neoplasm
2837 clinical trials for this condition and its sub-types, 9 tagged with Fibrosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Fibrosarcoma
-
Dermatofibrosarcoma protuberans 11 trials
1 sub-type
-
Low grade fibromyxoid sarcoma 4 trials
1 sub-type
-
Conventional fibrosarcoma 0 trials · 2 incl. sub-types
2 sub-types
- Congenital fibrosarcoma 2 trials
- Adult fibrosarcoma 0 trials
-
Pediatric fibrosarcoma 0 trials · 2 incl. sub-types
1 sub-type
- Congenital fibrosarcoma 2 trials
-
Bone fibrosarcoma 0 trials
-
Breast fibrosarcoma 0 trials
-
Central nervous system fibrosarcoma 0 trials
-
Heart fibrosarcoma 0 trials
-
Kidney fibrosarcoma 0 trials
-
Liver fibrosarcoma 0 trials
-
Small intestinal fibrosarcoma 0 trials
-
New drug aims to tame tumor-triggered low blood sugar in rare cancer patients
Disease control Recruiting nowThis study tests a new medicine called ersodetug for people whose tumors cause dangerously low blood sugar that standard treatments can't control. About 16 adults with insulin-producing tumors will receive the drug alongside their usual care. The main goal is to see if ersodetug …
Phase 3 • Sponsor: Rezolute • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return
Disease control Recruiting nowThis study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the drugs pazopanib and selinexor to standard chemotherapy can improve outcomes. Participants receive treatment tailored to their…
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for sarcoma patients: immunotherapy plus chemo shows promise
Disease control Recruiting nowThis study tests a new combination of drugs (tislelizumab, liposomal doxorubicin, and ifosfamide) as a first treatment for people with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. The goal is to see if this combo shrinks tumors and is safe. About …
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug access for rare Tumor-Induced low blood sugar
Disease control Expanded accessThis program provides an investigational drug, ersodetug, to people with dangerously low blood sugar caused by certain tumors. It is for those who cannot join a formal clinical trial. The goal is to help control blood sugar levels when standard treatments are not enough.
Sponsor: Rezolute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
3D printed models may speed up bone tumor surgery
Knowledge-focused Recruiting nowThis study looks at whether using 3D printed models of a patient's bones helps surgeons plan and perform tumor removal more effectively. About 150 people with bone tumors will take part, and half will have their surgery planned with both 3D models and regular scans, while the oth…
Sponsor: Ricoh USA, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC